Home/Pipeline/FIRSTGENE NIPT Technology Enabler

FIRSTGENE NIPT Technology Enabler

Prenatal Screening

Research/DevelopmentActive

Key Facts

Indication
Prenatal Screening
Phase
Research/Development
Status
Active
Company

About Apostle Inc

Apostle Inc. is a private, commercial-stage diagnostics company headquartered in San Jose, California, that has established itself as a specialized provider of liquid biopsy solutions. The company's business model integrates the sale of proprietary reagent kits (e.g., MiniMax for cfDNA), laboratory instruments (including ultra-low temperature freezers), and fee-for-service laboratory offerings such as cfDNA isolation and clinical trial support. With a clear focus on the growing liquid biopsy market, Apostle's technology platform aims to improve the sensitivity and efficiency of nucleic acid extraction, positioning it as an enabler for next-generation sequencing (NGS), digital PCR, and other advanced diagnostic applications in oncology and beyond.

View full company profile

Other Prenatal Screening Drugs

DrugCompanyPhase
UNITY Expanded RBC Fetal AntigenBillionToOneCommercial
UNITY Expanded Platelet Fetal AntigenBillionToOneCommercial